 
      
    Global leader in
Health Sciences M&A
        
        
          
        
    Our sole focus on the Health Sciences and Pharma Services empowers us to execute more industry-transactions than competitors 10x our size.
No. 1
Advisory for 
Pharma Services M&A
Top 10
In Pharma IT M&A
50+
Health Sciences-Focused Professionals
(Source: Industry Genome. Announced or Completed Transactions.)
Latest Transactions
.png) 
    IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates
.png) 
    Deep 6 AI Acquired by Tempus
.png) 
    Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools
.png) 
    Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business
 
    Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio
 
    Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities
 
    Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network
 
    Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network
 
    BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering
 
    Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe
.png) 
    Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US
.V3-1.png) 
    Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
%20(1).png) 
    physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
.png) 
    Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities
%20(NEW).png) 
    Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally
 
    Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering
 
    Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities
 
    Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities
 
    VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities
 
    Grant Avenue Capital Recapitalizes CREO
What We Do
We empower founders, investors, and operators to confidently connect with leading health sciences companies, align interests, and optimize outcomes.
Investment Banking Services
Strategic Advisory & Origination Services
Recapitalization Services
 
          Investment Banking Services
As a global M&A advisory firm, we're integral to the industries we serve. Our experienced senior bankers, with deep professional relationships and knowledge, deliver services tailored to our core industry focus.
 
          Strategic Advisory & Origination Services
We go beyond value creation. Achieve greater outcomes with our strategic advisory and origination services.
 
          Recapitalization Services
Our deep industry understanding allows us to align growth-oriented companies with financial partners who share a common strategic vision and growth objectives.
Our Focus
Our experienced senior bankers have spent their careers developing deep professional relationships and building in-depth knowledge of the companies, trends and insights relevant to the Health Science industry.
Pharma Services
We cover the entire Pharmaceutical Services industry, from development through commercialization
Learn MoreDiagnostics & Tools
Our extensive industry experience spans routine chemistries to the most esoteric of testing
Learn MoreHealthcare Technology
We are one of the handful of M&A firms with dedicated coverage to this rapidly shifting area
Featured Insights
 
      
     
      
    Pharma Services: Drug Supply Chain BlueBook March 2025
 
      
    Pharma Services: Pharmaceutical Commerce BlueBook March 2025
 
      
    Pharma Services: Pharma Technology BlueBook March 2025
 
      
    IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates
